Comparison of Hybrid and Laparoscopic Incisional Hernia Repair

September 4, 2015 updated by: Mirella Ahonen-Siirtola, Oulu University Hospital

Comparison of Hybrid and Laparoscopic Incisional Hernia Repair: A Prospective Randomized Multicentre Study

Study is a prospective, multicenter, randomized trial evaluating two laparoscopic incisional hernia repair methods: basic laparoscopic mesh repair (lap.) and a hybrid repair (laparoscopic mesh and fascial suturation).

Patients are recruited prospectively from 10 Finnish Hospitals (Oulu, Jorvi, Hyvinkää, Kotka, Seinäjoki, Valkeakoski, Lahti, Kuopio, Kokkola, Loimaa).

Patients are randomized to operative groups (lap. vs hybrid).

Follow-up visits are scheduled at 1- and 12-month after surgery. Patients are evaluated for their clinical status and an ultrasound scan is performed. QoL-questionnaire and pain score (VAS) are reported.

The primary end-points:

  • clinically and/or radiologically detected seroma in 1 month control
  • clinically and/or radiologically detected recurrent hernia in 1 year control

The secondary end-points:

  • peri-and postoperative outcomes/ complications, morbidity, mortality
  • duration of hospital stay
  • pain scale (VAS)
  • Quality of Life (SF/Rand36)

Study Overview

Status

Unknown

Conditions

Detailed Description

Hypothesis: Using a hybrid method seroma formation and hernia recurrence can be diminished.

Patient exclusion criteria:

Age< 18 y or > 80 y ASA >4 (the American Society of Anaesthesiologists' classification of Physical Health) BMI> 40 A previous mesh repair of the hernia Hernia defect size <2 or >7 cm Emergency operation

Eligible patients are randomized into two operative groups (lap/hybrid). In the laparoscopic group the hernia defect is covered with a Parietex composite mesh (using minimum of 5 cm marginals, Securestrap fixation instrument and four lifting strings. In hybrid group the hernia sack is resected and fascial defect is sutured through a minilaparotomy incision. After this, a mesh repair is performed laparoscopically.

Study Type

Interventional

Enrollment (Anticipated)

160

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

-Patients with incisional hernia

Exclusion Criteria:

  • BMI >40
  • ASA IV
  • a Prior mesh repair
  • Hernia defect size <2 or >7 cm
  • Emergency operation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: laparoscopic repair
patients who are randomized to have a laparoscopic mesh repair
operative method
Active Comparator: hybrid repair
patients who are randomized to have a laparoscopic mesh repair and fascial closure
operative method

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
number of patients with seroma formation
Time Frame: 1 month
1 month
number of patients with hernia recurrence
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of patients with peri/postoperative complications
Time Frame: up to 1 year
complications are reported perioperatively, during hospital stay, in 1 month control and in 1 year control
up to 1 year
VAS pain scale
Time Frame: 1 year
Pain scores (VAS) are measured during hospital day (average 3 days), in 1 month control and in 1 year control
1 year
Quality of Life
Time Frame: preoperative-1month-1year
patients are asked to fill SF/rand36-questionnaire preoperatively, in 1 month control and in 1 year control
preoperative-1month-1year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Tero Rautio, MD, PhD, Oulu University Hospital
  • Principal Investigator: Mirella Ahonen-Siirtola, MD, Oulu University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Anticipated)

August 1, 2016

Study Completion (Anticipated)

August 1, 2016

Study Registration Dates

First Submitted

August 31, 2015

First Submitted That Met QC Criteria

September 2, 2015

First Posted (Estimate)

September 4, 2015

Study Record Updates

Last Update Posted (Estimate)

September 7, 2015

Last Update Submitted That Met QC Criteria

September 4, 2015

Last Verified

September 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incisional Hernia

Clinical Trials on Laparoscopic repair

Subscribe